|

DF6002 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Dragonfly Therapeutics1

Indications

  • Solid Tumors1
  • Lung Cancer1
  • Cancer1

Orange, California1 trial

A Study of DF6002 Alone and in Combination With Nivolumab

University of California Irvine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.